Qingdao Baheal (China) Today
| 301015 Stock | 21.43 1.93 8.26% |
PerformanceVery Weak
| Odds Of DistressLow
|
Qingdao Baheal is trading at 21.43 as of the 24th of March 2025, a 8.26% down since the beginning of the trading day. The stock's open price was 23.36. Qingdao Baheal has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 24th of December 2024 and ending today, the 24th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Qingdao Baheal is entity of China. It is traded as Stock on SHE exchange. The company has 525.62 M outstanding shares. More on Qingdao Baheal Medical
Moving together with Qingdao Stock
| 0.64 | 601658 | Postal Savings Bank Earnings Call This Week | PairCorr |
Moving against Qingdao Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Qingdao Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Qingdao Baheal's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Qingdao Baheal or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman GM | Gang Fu | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | ||||
Qingdao Baheal's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Qingdao Baheal's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsQingdao Baheal can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Qingdao Baheal's financial leverage. It provides some insight into what part of Qingdao Baheal's total assets is financed by creditors.
| |||||
Qingdao Baheal Medical (301015) is traded on Shenzhen Stock Exchange in China and employs 2,642 people. Qingdao Baheal is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 11.26 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Qingdao Baheal's market, we take the total number of its shares issued and multiply it by Qingdao Baheal's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Qingdao Baheal Medical operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 525.62 M outstanding shares.
Qingdao Baheal generates positive cash flow from operations, but has no cash available
Check Qingdao Baheal Probability Of Bankruptcy
Ownership AllocationQingdao Baheal owns a total of 525.62 Million outstanding shares. Qingdao Baheal holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 77.6 pct. of Qingdao Baheal Medical outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Qingdao Ownership Details
Qingdao Baheal Medical Risk Profiles
Although Qingdao Baheal's alpha and beta are two of the key measurements used to evaluate Qingdao Baheal's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.37 | |||
| Standard Deviation | 1.89 | |||
| Variance | 3.58 | |||
| Risk Adjusted Performance | (0.16) |
Qingdao Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Qingdao Baheal without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Qingdao Baheal Corporate Executives
Elected by the shareholders, the Qingdao Baheal's board of directors comprises two types of representatives: Qingdao Baheal inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Qingdao. The board's role is to monitor Qingdao Baheal's management team and ensure that shareholders' interests are well served. Qingdao Baheal's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Qingdao Baheal's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Guoqiang Wang | CFO, GM | Profile |
Other Information on Investing in Qingdao Stock
Qingdao Baheal financial ratios help investors to determine whether Qingdao Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Qingdao with respect to the benefits of owning Qingdao Baheal security.